Novartis Investigative Site

Bursa, Gorukle 16059

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis — Completed